The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,735
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733
The roles of FLT3 in hematopoiesis and leukemia
Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,558
Kottaridis, P. D., Gale, R. E., Frew, M. E., Harrison, G., Langabeer, S. E., Belton, A. A., Walker, H., Wheatley, K., Bowen, D. T., Burnett, A. K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1752 · Cited by 1,551
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Pikman, Y., Lee, B. H., Mercher, T., McDowell, E., Ebert, B. L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030270 · Cited by 1,449
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065202 · Cited by 1,276
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Yamamoto, Y. (2001) · Blood · doi:10.1182/blood.v97.8.2434 · Cited by 1,150
Major nucleolar proteins shuttle between nucleus and cytoplasm
Borer, R. A., Lehner, C. F., Eppenberger, H. M., & Nigg, E. A. (1989) · Cell · doi:10.1016/0092-8674(89)90241-9 · Cited by 1,114
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
Pardanani, A. D., Levine, R. L., Lasho, T., Pikman, Y., Mesa, R. A., Wadleigh, M., Steensma, D. P., Elliott, M. A., Wolanskyj, A. P., Hogan, W. J., et al. (2006) · Blood · doi:10.1182/blood-2006-04-018879 · Cited by 1,056
Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Löffler, H., Sauerland, C. M., Serve, H., Büchner, T., et al. (2002) · Blood · doi:10.1182/blood.v100.1.59 · Cited by 973
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910
Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Fröhling, S., Schlenk, R. F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2002) · Blood · doi:10.1182/blood-2002-05-1440 · Cited by 871
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
O'Farrell, A.-M., Abrams, T. J., Yuen, H. A., Ngai, T. J., Louie, S. G., Yee, K. W. H., Wong, L. M., Hong, W., Lee, L. B., Town, A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2307 · Cited by 864
Döhner, K., Schlenk, R. F., Habdank, M., Scholl, C., Rücker, F. G., Corbacioglu, A., Bullinger, L., Fröhling, S., Döhner, H., & for the AML Study Group (AMLSG) (2005) · Blood · doi:10.1182/blood-2005-05-2164 · Cited by 849
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., et al. (1999) · PubMed · doi:10.1182/blood.v93.9.3074 · Cited by 757
Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M., Ehninger, G., & (DSIL), F. T. D. S. L. (2006) · Blood · doi:10.1182/blood-2005-08-3167 · Cited by 736
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Schnittger, S., Schoch, C., Kern, W., Mecucci, C., Tschulik, C., Martelli, M. F., Haferlach, T., Hiddemann, W., & Falini, B. (2005) · Blood · doi:10.1182/blood-2005-06-2248 · Cited by 713
Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication
Okuda, M., Horn, H. F., Tarapore, P., Tokuyama, Y., Smulian, A. G., Chan, P.-K., Knudsen, E. S., Hofmann, I. A., Snyder, J. D., Bove, K. E., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00093-3 · Cited by 685
Paschka, P., Marcucci, G., Ruppert, A. S., Mrózek, K., Chen, H., Kittles, R. A., Vukosavljevic, T., Perrotti, D., Vardiman, J. W., Carroll, A. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9500 · Cited by 663
Stone, R. M., DeAngelo, D. J., Klimek, V., Galinsky, I., Estey, E., Nimer, S. D., Grandin, W., Lebwohl, D., Wang, Y., Cohen, P., et al. (2005) · Blood · doi:10.1182/blood-2004-03-0891 · Cited by 657
Passegué, E., Wagers, A. J., Giuriato, S., Anderson, W. C., & Weissman, I. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050967 · Cited by 646
Whitman, S. P., Archer, K. J., Lin, F., Baldus, C. D., Becknell, B., Carlson, B. D., Carroll, A. J., Mrózek, K., Vardiman, J., George, S. L., et al. (2001) · PubMed · Cited by 633
Smith, B. D., Levis, M., Beran, M., Giles, F., Kantarjian, H., Berg, K., Murphy, K. M., Dauses, T., Allebach, J., & Small, D. (2004) · Blood · doi:10.1182/blood-2003-11-3775 · Cited by 632
The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo
Wang, Q., Stacy, T., Miller, J. D., Lewis, A. F., Gu, T.-L., Huang, X., Bushweller, J. H., Bories, J.-C., Alt, F. W., Ryan, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81389-6 · Cited by 621
Verhaak, R. G. W., Goudswaard, C. S., van Putten, W., Bijl, M. A., Sanders, M. A., Hugens, W., Uitterlinden, A. G., Erpelinck, C. A. J., Delwel, R., Löwenberg, B., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2168 · Cited by 618
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., & Fenaux, P. (1994) · Blood · doi:10.1182/blood.v84.9.3148.3148 · Cited by 591
Self-citationNucleophosmin regulates the stability and transcriptional activity of p53
Colombo, E., Marine, J.-C., Danovi, D., Falini, B., & Pelicci, P. G. (2002) · Nature Cell Biology · doi:10.1038/ncb814 · Cited by 528
Meshinchi, S., Woods, W. G., Stirewalt, D. L., Sweetser, D. A., Buckley, J. D., Tjoa, T. K., Bernstein, I. D., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.1.89 · Cited by 518
Preudhomme, C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0990 · Cited by 501
Self-citationFiedler, W., Serve, H., Döhner, H., Schwittay, M., Ottmann, O. G., O'Farrell, A.-M., Bello, C. L., Allred, R., Manning, W. C., Cherrington, J. M., et al. (2005) · Blood · doi:10.1182/blood-2004-05-1846 · Cited by 490
Localization of gene for human p53 tumour antigen to band 17p13
Isobe, M., Emanuel, B. S., Givol, D., Oren, M., & Croce, C. M. (1986) · Nature · doi:10.1038/320084a0 · Cited by 485
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
Levis, M., Allebach, J., Tse, K.-F., Zheng, R., Baldwin, B. R., Smith, B. D., Jones-Bolin, S., Ruggeri, B., Dionne, C., & Small, D. (2002) · Blood · doi:10.1182/blood.v99.11.3885 · Cited by 475
Radomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Fröhling, S., Schlenk, R. F., Stolze, I., Bihlmayr, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.060 · Cited by 458
Redner, R., Rush, E., Faas, S., Rudert, W., & Corey, S. (1996) · Blood · doi:10.1182/blood.v87.3.882.bloodjournal873882 · Cited by 442
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
Stirewalt, D. L., Kopecky, K. J., Meshinchi, S., Appelbaum, F. R., Slovak, M. L., Willman, C. L., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.11.3589 · Cited by 431
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
Romana, S., Poirel, H., Leconiat, M., Flexor, M., Mauchauffe, M., Jonveaux, P., Macintyre, E., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v86.11.4263.bloodjournal86114263 · Cited by 427
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D., & Laiho, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00110-2 · Cited by 416
Signaling Interplay in Ras Superfamily Function
Mitin, N., Rossman, K. L., & Der, C. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.010 · Cited by 399
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L., & Groner, Y. (1994) · Genomics · doi:10.1006/geno.1994.1519 · Cited by 391
Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R., & Darlington, G. J. (1996) · Genes & Development · doi:10.1101/gad.10.7.804 · Cited by 387
Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23
Bertwistle, D., Sugimoto, M., & Sherr, C. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.985-996.2004 · Cited by 380
Schnittger, S., Kohl, T. M., Haferlach, T., Kern, W., Hiddemann, W., Spiekermann, K., & Schoch, C. (2006) · Blood · doi:10.1182/blood-2005-04-1466 · Cited by 380
Cairoli, R. (2006) · Blood · doi:10.1182/blood-2005-09-3640 · Cited by 375
Jelinek, J., Oki, Y., Gharibyan, V., Bueso-Ramos, C., Prchal, J. T., Verstovsek, S., Beran, M., Estey, E., Kantarjian, H. M., & Issa, J.-P. J. (2005) · Blood · doi:10.1182/blood-2005-05-1800 · Cited by 369
Sasaki, K., Yagi, H., Bronson, R. T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T., & Komori, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12359 · Cited by 368
Boissel, N., Leroy, H., Brethon, B., Philippe, N., de Botton, S., Auvrignon, A., Raffoux, E., Leblanc, T., Thomas, X., Hermine, O., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404188 · Cited by 357
Self-citationAlcalay, M., Tiacci, E., Bergomas, R., Bigerna, B., Venturini, E., Minardi, S. P., Meani, N., Diverio, D., Bernard, L., Tizzoni, L., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0560 · Cited by 357
Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias
Carow, C., Levenstein, M., Kaufmann, S., Chen, J., Amin, S., Rockwell, P., Witte, L., Borowitz, M., Civin, C., & Small, D. (1996) · Blood · doi:10.1182/blood.v87.3.1089.bloodjournal8731089 · Cited by 345
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia
Kiyoi, H., Naoe, T., Yokota, S., Nakao, M., Minami, S., Kuriyama, K., Takeshita, A., Saito, K., Hasegawa, S., Shimodaira, S., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400756 · Cited by 344
Smith, L., Hohaus, S., Gonzalez, D., Dziennis, S., & Tenen, D. (1996) · Blood · doi:10.1182/blood.v88.4.1234.bloodjournal8841234 · Cited by 332
Mutation of CEBPA in Familial Acute Myeloid Leukemia
Smith, M. L., Cavenagh, J. D., Lister, T. A., & Fitzgibbon, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041331 · Cited by 328
Mead, A. J., Linch, D. C., Hills, R. K., Wheatley, K., Burnett, A. K., & Gale, R. E. (2007) · Blood · doi:10.1182/blood-2006-04-015826 · Cited by 327
AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
Nucifora, G., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.1.1.bloodjournal8611 · Cited by 324
Transcriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 324
Care, R. S., Valk, P. J. M., Goodeve, A. C., Abu‐Duhier, F. M., Geertsma‐Kleinekoort, W. M. C., Wilson, G. A., Gari, M. A., Peake, I. R., Löwenberg, B., & Reilly, J. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04362.x · Cited by 323
BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
Perrotti, D., Cesi, V., Trotta, R., Guerzoni, C., Santilli, G., Campbell, K., Iervolino, A., Condorelli, F., Gambacorti-Passerini, C., Caligiuri, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng791 · Cited by 313
O'Farrell, A.-M., Foran, J. M., Fiedler, W., Serve, H. L., Paquette, R. L., Cooper, M. A., Yuen, H. A., Louie, S. G., Kim, H., Nicholas, S., et al. (2003) · PubMed · Cited by 310
Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1405 · Cited by 308
Kottaridis, P. D., Gale, R. E., Langabeer, S. E., Frew, M. E., Bowen, D. T., & Linch, D. C. (2002) · Blood · doi:10.1182/blood-2002-02-0420 · Cited by 307
Shih, L.-Y., Huang, C.-F., Wu, J.-H., Lin, T.-L., Dunn, P., Wang, P.-N., Kuo, M.-C., Lai, C.-L., & Hsu, H.-C. (2002) · Blood · doi:10.1182/blood-2002-01-0195 · Cited by 306
Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit
Lennartsson, J., Jelacic, T., Linnekin, D., & Shivakrupa, R. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0117 · Cited by 303
Implications of NRAS mutations in AML: a study of 2502 patients
Bacher, U., Haferlach, T., Schoch, C., Kern, W., & Schnittger, S. (2006) · Blood · doi:10.1182/blood-2005-08-3522 · Cited by 303
Gorello, P., Cazzaniga, G., Alberti, F., Dell'Oro, M. G., Gottardi, E., Specchia, G., Roti, G., Rosati, R., Martelli, M. F., Diverio, D., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404149 · Cited by 301
C-kit mutations in core binding factor leukemias
Beghini, A., Peterlongo, P., Ripamonti, C. B., Larizza, L., Cairoli, R., Morra, E., & Mecucci, C. (2000) · Blood · doi:10.1182/blood.v95.2.726 · Cited by 299
Gombart, A. F., Hofmann, W.-K., Kawano, S., Takeuchi, S., Krug, U., Kwok, S. H., Larsen, R. J., Asou, H., Miller, C. W., Hoelzer, D., et al. (2002) · Blood · doi:10.1182/blood.v99.4.1332 · Cited by 293
Yanada, M., Matsuo, K., Suzuki, T., Kiyoi, H., & Naoe, T. (2005) · Leukemia · doi:10.1038/sj.leu.2403838 · Cited by 289
Harada, H., Harada, Y., Niimi, H., Kyo, T., Kimura, A., & Inaba, T. (2004) · Blood · doi:10.1182/blood-2003-09-3074 · Cited by 281
C/EBPα mutations in acute myeloid leukaemias
Nerlov, C. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1363 · Cited by 280
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia
Suzuki, T. (2005) · Blood · doi:10.1182/blood-2005-04-1733 · Cited by 277
Yoneda‐Kato, N., Look, A. T., Kirstein, M. N., Valentine, M. B., Sc, R., Cohen, K. J., Carroll, A. J., & Morris, S. W. (1996) · PubMed · Cited by 274
Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia
Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T., Yokoyama, K., Soceda, E., & Ohkl, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2762 · Cited by 264
Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2862 · Cited by 263
Self-citationChoudhary, C., Schwäble, J., Brandts, C., Tickenbrock, L., Sargin, B., Kindler, T., Fischer, T., Berdel, W. E., Müller-Tidow, C., & Serve, H. (2005) · Blood · doi:10.1182/blood-2004-07-2942 · Cited by 263
c-Myc Is a Critical Target for C/EBPα in Granulopoiesis
Johansen, L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., & Tenen, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3789-3806.2001 · Cited by 263
c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia
Gari, M., Goodeve, A., Wilson, G., Winship, P., Langabeer, S., Linch, D., Vandenberghe, E., Peake, I., & Reilly, J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01449.x · Cited by 262
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia
Fiedler, W., Mesters, R., Tinnefeld, H., Loges, S., Staib, P., Dührsen, U., Flasshove, M., Ottmann, O. G., Jung, W., Cavalli, F., et al. (2003) · Blood · doi:10.1182/blood-2002-10-2998 · Cited by 262
Cai, Z., de Bruijn, M., Ma, X., Dortland, B., Luteijn, T., Downing, J. R., & Dzierzak, E. (2000) · Immunity · doi:10.1016/s1074-7613(00)00042-x · Cited by 254
Gleixner, K. V., Mayerhofer, M., Aichberger, K. J., Derdak, S., Sonneck, K., Böhm, A., Gruze, A., Samorapoompichit, P., Manley, P. W., Fabbro, D., et al. (2006) · Blood · doi:10.1182/blood-2005-07-3022 · Cited by 250
Growney, J. D., Clark, J. J., Adelsperger, J., Stone, R., Fabbro, D., Griffin, J. D., & Gilliland, D. G. (2005) · Blood · doi:10.1182/blood-2004-12-4617 · Cited by 249
Alcalay, M., Meani, N., Gelmetti, V., Fantozzi, A., Fagioli, M., Orleth, A., Riganelli, D., Sebastiani, C., Cappelli, E., Casciari, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17595 · Cited by 249
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
Goemans, B. F., Zwaan, C. M., Miller, M., Zimmermann, M., Harlow, A., Meshinchi, S., Loonen, A. H., Hählen, K., Reinhardt, D., Creutzig, U., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403870 · Cited by 243
Fitzgibbon, J., Smith, L.-L., Raghavan, M., Smith, M. L., Debernardi, S., Skoulakis, S., Lillington, D., Lister, T. A., & Young, B. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2017 · Cited by 241
Stirewalt, D. L., Kopecky, K. J., Meshinchi, S., Engel, J. H., Pogosova-Agadjanyan, E. L., Linsley, J., Slovak, M. L., Willman, C. L., & Radich, J. P. (2006) · Blood · doi:10.1182/blood-2005-08-3453 · Cited by 239
Gualberto, A., Aldape, K., Kozakiewicz, K., & Tlsty, T. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5166 · Cited by 237
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
Bienz, M., Ludwig, M., Mueller, B. U., Oppliger Leibundgut, E., Ratschiller, D., Solenthaler, M., Fey, M. F., & Pabst, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1552 · Cited by 235
van Waalwijk van Doorn-Khosrovani, S. B., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L. J., Valk, P. J. M., Berna Beverloo, H., Tenen, D. G., Löwenberg, B., & Delwel, R. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200216 · Cited by 235
Lee, B. H., Tothova, Z., Levine, R. L., Anderson, K., Buza-Vidas, N., Cullen, D. E., McDowell, E. P., Adelsperger, J., Fröhling, S., Huntly, B. J. P., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.031 · Cited by 230
Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., & Hirai, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07008.x · Cited by 224
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype
Boissel, N. (2005) · Blood · doi:10.1182/blood-2005-05-2174 · Cited by 224
Self-citationp53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.
Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R., & Glazer, P. M. (1995) · PubMed · Cited by 223
Gale, R. E., Hills, R., Kottaridis, P. D., Srirangan, S., Wheatley, K., Burnett, A. K., & Linch, D. C. (2005) · Blood · doi:10.1182/blood-2005-03-1323 · Cited by 214
Lin, L.-I., Chen, C.-Y., Lin, D.-T., Tsay, W., Tang, J.-L., Yeh, Y.-C., Shen, H.-L., Su, F.-H., Yao, M., Huang, S.-Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1816 · Cited by 214
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Sargin, B., Choudhary, C., Crosetto, N., Schmidt, M. H. H., Grundler, R., Rensinghoff, M., Thiessen, C., Tickenbrock, L., Schwäble, J., Brandts, C., et al. (2007) · Blood · doi:10.1182/blood-2007-01-066076 · Cited by 213
Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
Lutterbach, B., & Hiebert, S. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00014-7 · Cited by 209
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
Neubauer, A., Dodge, R., George, S., Davey, F., Silver, R., Schiffer, C., Mayer, R., Ball, E., Wurster-Hill, D., & Bloomfield, C. (1994) · Blood · doi:10.1182/blood.v83.6.1603.1603 · Cited by 199
Wouters, B. J., Jordà, M. A., Keeshan, K., Louwers, I., Erpelinck-Verschueren, C. A. J., Tielemans, D., Langerak, A. W., He, Y., Yashiro-Ohtani, Y., Zhang, P., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073486 · Cited by 199
Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations
Radomska, H. S., Bassères, D. S., Zheng, R., Zhang, P., Dayaram, T., Yamamoto, Y., Sternberg, D. W., Lokker, N., Giese, N. A., Bohlander, S. K., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052242 · Cited by 199
Laï, J., Preudhomme, C., Zandecki, M., FLACTIF, M., Vanrumbeke, M., Lepelley, P., Wattel, E., & Fenaux, P. (1995) · PubMed · Cited by 197
Self-citationFröhling, S., Scholl, C., Levine, R. L., Loriaux, M., Boggon, T. J., Bernard, O. A., Berger, R., Döhner, H., Döhner, K., Ebert, B. L., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.005 · Cited by 197
Grundler, R., Miething, C., Thiede, C., Peschel, C., & Duyster, J. (2005) · Blood · doi:10.1182/blood-2004-11-4430 · Cited by 193
RAS and Leukemia: From Basic Mechanisms to Gene-Directed Therapy
Beaupre, D. M., & Kurzrock, R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1071 · Cited by 192
CEBPA point mutations in hematological malignancies
Leroy, H., Roumier, C., Huyghe, P., Biggio, V, Fenaux, P., & Preudhomme, C. (2005) · Leukemia · doi:10.1038/sj.leu.2403614 · Cited by 190
Self-citationLevis, M., Tse, K.-F., Smith, B. D., Garrett, E., & Small, D. (2001) · Blood · doi:10.1182/blood.v98.3.885 · Cited by 189
Noguera, N., Breccia, M., Divona, M., Diverio, D., Costa, V, De Santis, S., Avvisati, G., Pinazzi, M., Petti, M., Mandelli, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402723 · Cited by 183
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
Cloos, J., Goemans, B. F., Hess, C. J., van Oostveen, J. W., Waisfisz, Q., Corthals, S., de Lange, D., Boeckx, N., Hählen, K., Reinhardt, D., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404246 · Cited by 179
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
Cazzaniga, G., Dell'Oro, M. G., Mecucci, C., Giarin, E., Masetti, R., Rossi, V., Locatelli, F., Martelli, M. F., Basso, G., Pession, A., et al. (2005) · Blood · doi:10.1182/blood-2005-03-0899 · Cited by 178
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells
Gal, H., Amariglio, N., Trakhtenbrot, L., Jacob‐Hirsch, J., Margalit, O., Avigdor, A., Nagler, A., Tavor, S., Ein‐Dor, L., Lapidot, T., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404401 · Cited by 176
P53 gene mutations in acute myeloid leukemia with 17p monosomy
Fenaux, P., Jonveaux, P., Quiquandon, I., Lai, J., Pignon, J., Loucheux-Lefebvre, M., Bauters, F., Berger, R., & Kerckaert, J. (1991) · Blood · doi:10.1182/blood.v78.7.1652.1652 · Cited by 175
Self-citationIwai, T., Yokota, S., Nakao, M., Okamoto, T., Taniwaki, M., Onodera, N., Watanabe, A., Kikuta, A., Tanaka, A., Asami, K., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401241 · Cited by 173
Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki, K., Ogawa, S., Chiba, S., Mitani, K., & Hirai, H. (2000) · Blood · doi:10.1182/blood.v96.9.3154 · Cited by 172
Chou, W.-C., Tang, J.-L., Lin, L.-I., Yao, M., Tsay, W., Chen, C.-Y., Wu, S.-J., Huang, C.-F., Chiou, R.-J., Tseng, M.-H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4316 · Cited by 172
Ellisen, L. W. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1897 · Cited by 168
Molecular genetics of acute myeloid leukaemia
Dash, A., & Gilliland, D. G. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0115 · Cited by 166
Baldus, C. D., Thiede, C., Soucek, S., Bloomfield, C. D., Thiel, E., & Ehninger, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6253 · Cited by 163
Jak family of kinases in cancer
Verma, A., Kambhampati, S., Parmar, S., & Platanias, L. C. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023805715476 · Cited by 161
Interaction of nucleolar phosphoprotein B23 with nucleic acids
Dumbar, T. S., Gentry, G. A., & Olson, M. O. J. (1989) · Biochemistry · doi:10.1021/bi00450a037 · Cited by 161
Beghini, A., Ripamonti, C. B., Cairoli, R., et al. (2004) · PubMed · Cited by 161
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance
Radich, J., Kopecky, K., Willman, C., Weick, J., Head, D., Appelbaum, F., & Collins, S. (1990) · Blood · doi:10.1182/blood.v76.4.801.801 · Cited by 161
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Caligiuri, M. A., Briesewitz, R., Yu, J., Wang, L., Wei, M., Arnoczky, K. J., Marburger, T. B., Wen, J., Perrotti, D., Bloomfield, C. D., et al. (2007) · Blood · doi:10.1182/blood-2006-12-061176 · Cited by 156
Whitman, S. P., Liu, S., Vukosavljevic, T., Rush, L. J., Yu, L., Liu, C., Klisovic, M. I., Maharry, K. S., Guimond, M., Strout, M. P., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0204 · Cited by 153
Chian, R., Young, S. M., Danilkovitch‐Miagkova, A., Rönnstrand, L., Leonard, E. J., Ferrao, P., Ashman, L. K., & Linnekin, D. (2001) · Blood · doi:10.1182/blood.v98.5.1365 · Cited by 149
Steensma, D. P., McClure, R. F., Karp, J. E., Tefferi, A., Lasho, T. L., Powell, H. L., Dewald, G., & Kaufmann, S. H. (2006) · Leukemia · doi:10.1038/sj.leu.2404206 · Cited by 148
Delocalization and Destabilization of the Arf Tumor Suppressor by the Leukemia-Associated NPM Mutant
Colombo, E., Martinelli, P., Zamponi, R., Shing, D. C., Bonetti, P., Luzi, L., Volorio, S., Bernard, L., Pruneri, G., Alcalay, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2378 · Cited by 147
New mechanisms of AML1 gene alteration in hematological malignancies
Roumier, C., Fenaux, P., Lafage‐Pochitaloff, M., Imbert, M., Éclache, V., & Preudhomme, C. (2003) · Leukemia · doi:10.1038/sj.leu.2402766 · Cited by 146
Self-citationScholl, C., Bansal, D., Döhner, K., Eiwen, K., Huntly, B. J. P., Lee, B. H., Rücker, F. G., Schlenk, R. F., Bullinger, L., Döhner, H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30182 · Cited by 145
Shih, L.-Y., Huang, C.-F., Wang, P.-N., Jh, W., Lin, T.-L., Dunn, P., & Kuo, M.-C. (2004) · Leukemia · doi:10.1038/sj.leu.2403274 · Cited by 145
Reindl, C., Bagrintseva, K., Vempati, S., Schnittger, S., Ellwart, J. W., Wenig, K., Hopfner, K., Hiddemann, W., & Spiekermann, K. (2006) · Blood · doi:10.1182/blood-2005-06-2596 · Cited by 143
Kikuchi, T., Moore, M. A. S., & Crystal, R. G. (2000) · Blood · doi:10.1182/blood.v96.1.91 · Cited by 142
Soenen, V., Preudhomme, C., Roumier, C., Daudignon, A., Laı̈, J. L., & Fenaux, P. (1998) · Blood · doi:10.1182/blood.v91.3.1008 · Cited by 134
Self-citationMutation of the p53 gene in human acute myelogenous leukemia
Slingerland, J., Minden, M., & Benchimol, S. (1991) · Blood · doi:10.1182/blood.v77.7.1500.bloodjournal7771500 · Cited by 130
Rhoades, K. L., Hetherington, C. J., Rowley, J. D., Hiebert, S. W., Nucifora, G., Tenen, D. G., & Zhang, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11895 · Cited by 129
Huntly, B. J. P., & Gilliland, D. G. (2005) · Nature · doi:10.1038/4351169a · Cited by 128
Dorrance, A. M., Liu, S., Yuan, W., Becknell, B., Arnoczky, K. J., Guimond, M., Strout, M. P., Feng, L., Nakamura, T., Yu, L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25546 · Cited by 128
Dicker, F., Haferlach, C., Kern, W., Haferlach, T., & Schnittger, S. (2007) · Blood · doi:10.1182/blood-2007-02-072595 · Cited by 127
Radmacher, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-005538 · Cited by 122
Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.
Bouffler, S. D., Kemp, C. J., Balmain, A., & Cox, R. (1995) · PubMed · Cited by 121
Loh, M. L., Reynolds, M. G., Vattikuti, S., Gerbing, R. B., Alonzo, T. A., Carlson, E. J., Cheng, J. W., Lee, C. M., Lange, B. J., & Meshinchi, S. (2004) · Leukemia · doi:10.1038/sj.leu.2403492 · Cited by 121
Christiansen, D. H., Andersen, M. K., Desta, F. Z., & Pedersen-Bjergaard, J. (2005) · Leukemia · doi:10.1038/sj.leu.2404009 · Cited by 121
AML1A and AML1B can transactivate the human IL-3 promoter
Uchida, H., Zhang, J., & Nimer, S. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2251 · Cited by 121
SHP-2 and myeloid malignancies
Tartaglia, M., Niemeyer, C. M., Shannon, K., & Loh, M. L. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200401000-00007 · Cited by 118
Mercher, T., Wernig, G., Moore, S. A., Levine, R. L., Gu, T.-L., Fröhling, S., Cullen, D., Polakiewicz, R. D., Bernard, O., Boggon, T. J., et al. (2006) · Blood · doi:10.1182/blood-2006-04-014712 · Cited by 116
Core-binding factor: a central player in hematopoiesis and leukemia.
Speck, N. A., Stacy, T., Wang, Q., North, T. E., Gu, T.-L., Miller, J., Binder, M., & Marin-Padilla, M. (1999) · PubMed · Cited by 114
Effect of transcription-factor concentrations on leukemic stem cells
Rosenbauer, F., Koschmieder, S., Steidl, U. G., & Tenen, D. G. (2005) · Blood · doi:10.1182/blood-2005-02-0717 · Cited by 110
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2
Snaddon, J., Smith, M. L., Neat, M. J., Cambal‐Parrales, M., Dixon‐McIver, A., Arch, R., Amess, J. A. L., Rohatiner, A. Z. S., Lister, T. A., & Fitzgibbon, J. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10185 · Cited by 109
Agnès, F., Shamoon, B., Dina, C., Rosnet, O., Birnbaum, D., & Galibert, F. (1994) · Gene · doi:10.1016/0378-1119(94)90021-3 · Cited by 108
FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress
Libura, M. A., Asnafi, V., Tu, A., Delabesse, É., Tigaud, I., Cymbalista, F., Griscelli, A. B., Villarèse, P., Solbu, G., Hagemeijer, A., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0162 · Cited by 106
Merlat, A., Lai, J.-L., Sterkers, Y., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401298 · Cited by 99
D’Alò, F., Johansen, L. M., Nelson, E. A., Radomska, H. S., Evans, E. K., Zhang, P., Nerlov, C., & Tenen, D. G. (2003) · Blood · doi:10.1182/blood-2003-02-0479 · Cited by 99
Helbling, D. C., Mueller, B. U., Timchenko, N. A., Schardt, J., Eyer, M., Betts, D. R., Jotterand, M., Meyer‐Monard, S., Fey, M. F., & Pabst, T. (2005) · Blood · doi:10.1182/blood-2004-11-4392 · Cited by 98
Kohl, T. M., Schnittger, S., Ellwart, J. W., Hiddemann, W., & Spiekermann, K. (2004) · Blood · doi:10.1182/blood-2004-06-2068 · Cited by 97
STAT3 activation is required for Asp816 mutant c-Kit induced tumorigenicity
Ning, Z.-Q., Li, J., McGuinness, M., & Arceci, R. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204590 · Cited by 94
Isoform-Specific Potentiation of Stem and Progenitor Cell Engraftment by AML1/RUNX1
Tsuzuki, S., Hong, D., Gupta, R., Matsuo, K., Seto, M., & Enver, T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040172 · Cited by 92
Helbling, D., Mueller, B. U., Timchenko, N. A., Hagemeijer, A., Jotterand, M., Meyer‐Monard, S., Lister, A. T., Rowley, J. D., Huegli, B., Fey, M. F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404731101 · Cited by 89
Motor performance of children during treatment for acute lymphoblastic leukemia
Reinders‐Messelink, H. A., Schoemaker, M. M., Snijders, T. A. B., G�eken, L., van den Briel, M. M., B�kkerink, J. P. M., & Kamps, W. A. (1999) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199912)33:6<525::aid-mpo1>3.0.co;2-8 · Cited by 88
Receptor tyrosine kinases in normal and malignant haematopoiesis
Reilly, J. T. (2003) · Blood Reviews · doi:10.1016/s0268-960x(03)00024-9 · Cited by 87
Pozner, A., Lotem, J., Xiao, C., Goldenberg, D., Brenner, O. J., Negreanu, V., Levanon, D., & Groner, Y. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-84 · Cited by 85
Corbacioglu, S., Kılıç, M., Westhoff, M., Reinhardt, D., Fulda, S., & Debatin, K. (2006) · Blood · doi:10.1182/blood-2006-05-021691 · Cited by 78
Somatic PTPN11 mutations in childhood acute myeloid leukaemia
Tartaglia, M., Martinelli, S., Iavarone, I., Cazzaniga, G., Spinelli, M., Giarin, E., Petrangeli, V., Carta, C., Masetti, R., Aricò, M., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05457.x · Cited by 77
Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia
Sellick, G. S., Spendlove, H. E., Catovsky, D., Pritchard‐Jones, K., & Houlston, R. S. (2005) · Leukemia · doi:10.1038/sj.leu.2403788 · Cited by 75
Okuda, T., Takeda, K., Fujita, Y., Nishimura, M., Yagyu, S., Yoshida, M., Akira, S., Downing, J. R., & Abe, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.319-328.2000 · Cited by 71
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
Wadleigh, M., DeAngelo, D. J., Griffin, J. D., & Stone, R. M. (2004) · Blood · doi:10.1182/blood-2003-11-3896 · Cited by 65
Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia
Stirewalt, D. L., Meshinchi, S., Kussick, S. J., Sheets, K. M., Pogosova‐Agadjanyan, E. L., Willman, C. L., & Radich, J. P. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04808.x · Cited by 63
Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7
Langabeer, S. E., Gale, R. E., Rollinson, S. J., Morgan, G. J., & Linch, D. C. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10031 · Cited by 62
Matsuno, N., Osato, M., Yamashita, N., Yanagida, M., Nanri, T., Fukushima, T., Motoji, T., KUSUMOTO, S., Towatari, M., Suzuki, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403160 · Cited by 60
Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7
Fröhling, S., Lipka, D. B., Käyser, S., Scholl, C., Schlenk, R. F., Döhner, H., Gilliland, D. G., Levine, R. L., & Döhner, K. (2006) · Blood · doi:10.1182/blood-2005-09-3644 · Cited by 58
Suela, J., Álvarez, S., Cifuentes, F., Largo, C., Ferreira, B. I., Blesa, D., Ardanaz, M. T., García, R., Marquez, J. A., Odero, M. D., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404653 · Cited by 56
Ponziani, V., Gianfaldoni, G., Mannelli, F., Leoni, F., Ciolli, S., Guglielmelli, P., Antonioli, E., Longo, G., Bosi, A., & Vannucchi, A. M. (2006) · Leukemia · doi:10.1038/sj.leu.2404368 · Cited by 56
Cited by
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Tang, J.-L., Hou, H.-A., Chen, C.-Y., Liu, C.-Y., Chou, W.-C., Tseng, M.-H., Huang, C.-F., Lee, F.-Y., Liu, M.-C., Yao, M., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223784 · Cited by 344
The role of HOX genes in normal hematopoiesis and acute leukemia
Alharbi, R. A., Pettengell, R., Pandha, H. S., & Morgan, R. (2013) · Leukemia · doi:10.1038/leu.2012.356 · Cited by 335
Leukaemogenesis: more than mutant genes
Chen, J., Odenike, O., & Rowley, J. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2765 · Cited by 311
Dunbar, A. J., Gondek, L. P., O'Keefe, C. L., Makishima, H., Rataul, M. S., Szpurka, H., Sekeres, M. A., Wang, X. F., McDevitt, M. A., & Maciejewski, J. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2754 · Cited by 299
Metadata
- Authors
- Renneville, A., Roumier, C., Biggio, V, Nibourel, O., Boissel, N., Fenaux, P., & Preudhomme, C.
- Venue
- Leukemia
- Published
- 2008-02-21
- Volume
- 22
- Issue
- 5
- Pages
- 915-931
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2041715533
- Cited by
- 351
- References
- 224
- FWCI
- 23.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.